Investing News

Carl Icahn and Illumina Proxy Fight Heats Up

Biotech firm Illumina (ILMN) told shareholders not to vote for the board nominees put forward by billionaire activist investor Carl Icahn.

Articles You May Like

Alphabet Stock Sell Alert: Why It’s Time to Ditch Good Ol’ GOOG
Bet Against the Crowd: 3 Stocks Set to Surge Against All Odds
3 Restaurant Stocks to Buy Now: May 2024
3 Blockchain Stocks to Buy Now: May 2024
Red Flags Rising: Avoid a Troublesome Trade With Nio Stock